BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16982902)

  • 1. Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy.
    Bodas M; Jain N; Awasthi A; Martin S; Penke Loka RK; Dandekar D; Mitra D; Saha B
    J Immunol; 2006 Oct; 177(7):4636-43. PubMed ID: 16982902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Roles for CD4
    Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
    J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
    Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
    PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.
    Chowdhury BP; Das S; Majumder S; Halder K; Ghosh S; Biswas S; Bandyopadhyay S; Majumdar S
    Pathog Dis; 2015 Nov; 73(8):ftv063. PubMed ID: 26297915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.
    Bhattacharya P; Ghosh S; Ejazi SA; Rahaman M; Pandey K; Ravi Das VN; Das P; Goswami RP; Saha B; Ali N
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004422. PubMed ID: 26829554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
    J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
    Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
    Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis.
    Paul J; Naskar K; Chowdhury S; Chakraborti T; De T
    Biochimie; 2014 Dec; 107 Pt B():235-46. PubMed ID: 25223889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
    Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 negatively regulates the production of inflammatory cytokines/chemokines and IL-17 in visceral leishmaniasis.
    Saha A; Biswas A; Srivastav S; Mukherjee M; Das PK; Ukil A
    J Immunol; 2014 Sep; 193(5):2330-9. PubMed ID: 25049356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani.
    Guha R; Das S; Ghosh J; Naskar K; Mandala A; Sundar S; Dujardin JC; Roy S
    Vaccine; 2013 Apr; 31(15):1905-15. PubMed ID: 23499564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE; Ng W; Wilson CB; McMaster WR; Burchett SK
    J Clin Invest; 1990 Jun; 85(6):1914-24. PubMed ID: 2112157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.